S

START | Barcelona

Research site

(Unclaimed)

Location

Avinguda de Vallcarca 151, Barcelona, Barcelona, Spain

Site insights

Top conditions

Top treatments

Tavapadon

TX000045

Emricasan

ARGX-113

Anecortave Acetate

Telaprevir

Ribavirin

Methylprednisolone

Peginterferon

PPSGG

Parent organization

This site is a part of START

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 16 total trials

A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)

TX000045-003 is a double-blind, randomized, parallel group, placebo-controlled, proof- of-concept (POC) study, evaluating 2 dose regimens of TX000045...

Enrolling

Heart Failure With Preserved Ejection Fraction

Pulmonary Hypertension

Drug: TX000045- Dose A

Drug: TX000045- Dose B

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

The primary purpose of this study is to assess the effect of TX000045 on pulmonary vascular resistance (PVR) in participants with pulmonary hypertens...

Not yet enrolling

Lung Diseases, Interstitial

Hypertension, Pulmonary

Drug: TX000045